Empagliflozin vs Simvastatin
Empagliflozin vs Simvastatin: Overview
This comparison examines the pharmacological differences between Empagliflozin and Simvastatin.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Simvastatin β 2 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Simvastatin β C25H38O5.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Simvastatin β 418.5700 g/mol.
Type: Empagliflozin β Small molecule; Simvastatin β Small molecule.